Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease

European Journal of Clinical Investigation

Volumn 39, Issue 5, 2009, Pages 359-367

  Minami, Y ^a   Satoh, M ^a   Maesawa, C ^a   Takahashi, Y ^a   Tabuchi, T ^a   Itoh, T ^a   Nakamura, M ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Flow cytometry; Real time PCR; Stable angina pectoris; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; NITRATE; PRAVASTATIN;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CELL COUNT; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; STEM CELL; TREATMENT DURATION;

AGED; ANTICHOLESTEREMIC AGENTS; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PRAVASTATIN; PROSPECTIVE STUDIES; PYRROLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SINGLE-BLIND METHOD; STATISTICS AS TOPIC; STEM CELLS;

EID: 63849261167     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02110.x     Document Type: Article

References (31)

1. Lusis AJ. Atherosclerosis. Nature 2000 407 : 233 41.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 : 964 7.
3. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998 92 : 362 7.
4. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005 353 : 999 1007.
5. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 103 : 2885 90.
6. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001 108 : 391 7.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 : 281 97.
8. Kim VN. Small RNAs: classification, biogenesis, and function. Mol Cells 2005 19 : 1 15.
9. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol Cell 2006 21 : 533 42.
10. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006 108 : 3068 71.
11. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005 102 : 18081 6.
12. Tuccoli A, Poliseno L, Rainaldi G. miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation. Cell Cycle 2006 5 : 2473 6.
13. Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007 21 : 1141 9.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001 25 : 402 8.
15. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002 106 : 653 8.
16. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 348 : 593 600.
17. Tousoulis D, Andreou I, Antoniades C, Tentolouris C, Stefanadis C. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008 201 : 236 47.
18. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007 100 : 1164 73.
19. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 : 15 20.
20. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004 101 : 2999 3004.
21. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 2005 33 : 2697 706.
22. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003 9 : 1370 6.
23. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004 110 : 1933 9.
24. Mason RP, Walter MF, Day CA, Jacob RF. Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism. J Biol Chem 2006 281 : 9337 45.
25. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002 105 : 3017 24.
26. Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003 92 : 1049 55.
27. Shilo S, Roy S, Khanna S, Sen CK. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 2008 28 : 471 7.
28. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002 22 : 300 5.
29. Chisolm GM III., Hazen SL, Fox PL, Cathcart MK. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 1999 274 : 25959 62.
30. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 43.
31. Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL et al. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler Thromb Vasc Biol 2007 27 : 1346 53.